follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Insmed announces $58M public offering

By

Back to Top Comments Email Print

Insmed, a pharmaceutical company in the Monmouth Junction section of South Brunswick, announced Wednesday a public offering of 6 million shares of common stock at $10.40 per share. Net proceeds are expected to be approximately $58 million.

Leerink Swann LLC is acting as sole book-running manager for the offering. Lazard Capital Markets LLC and Canaccord Genuity Inc. are acting as co-managers of the offering. Insmed granted the underwriters a 30-day option to purchase 0.9 million additional shares of common stock at the offering price to cover any overallotment.

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top